These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9394328)

  • 21. [A case of cyclosporin A-induced myopathy].
    Yamanishi Y; Ishibe Y; Taooka Y; Mukuzono H; Aoi K; Yamana S
    Ryumachi; 1993 Feb; 33(1):63-7. PubMed ID: 8493586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of Colchicine-Associated Myopathy in Gout: Influence of Concomitant Use of Statin.
    Kwon OC; Hong S; Ghang B; Kim YG; Lee CK; Yoo B
    Am J Med; 2017 May; 130(5):583-587. PubMed ID: 28065770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Toxic myopathy with kidney failure as a colchicine side effect ifn familial Mediterranean fever].
    Stefanidis I; Böhm R; Hägel J; Maurin N
    Dtsch Med Wochenschr; 1992 Aug; 117(33):1237-40. PubMed ID: 1499522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased incidence of benign breast disease in female renal transplant patients receiving cyclosporin.
    Sangthawan P; Fox J; Atkins RC; Kerr PG
    ANZ J Surg; 2002 Mar; 72(3):222-5. PubMed ID: 12071457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation.
    Brown JH; Murphy BG; Douglas AF; Short CD; Bhatnagar D; Mackness MI; Hunt LP; Doherty CC; Durrington PN
    Nephron; 1997; 75(3):277-82. PubMed ID: 9069448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ionized and total magnesium levels in cyclosporin-treated renal transplant recipients: relationship with cholesterol and cyclosporin levels.
    Markell MS; Altura BT; Barbour RL; Altura BM
    Clin Sci (Lond); 1993 Sep; 85(3):315-8. PubMed ID: 8403804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colchicine myopathy and neuropathy.
    Kuncl RW; Duncan G; Watson D; Alderson K; Rogawski MA; Peper M
    N Engl J Med; 1987 Jun; 316(25):1562-8. PubMed ID: 3035372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute myopathy in a patient with concomitant use of pravastatin and colchicine.
    Alayli G; Cengiz K; Cantürk F; Durmuş D; Akyol Y; Menekşe EB
    Ann Pharmacother; 2005; 39(7-8):1358-61. PubMed ID: 15914514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristic imaging features of breast fibroadenomas in women given cyclosporin A after renal transplantation.
    Son EJ; Oh KK; Kim EK; Cho N; Lee JD; Kim SH; Jung WH
    J Clin Ultrasound; 2004 Feb; 32(2):69-77. PubMed ID: 14750137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute toxic myopathy due to pyrazinamide in a patient with renal transplantation and cyclosporine therapy.
    Fernández-Solà J; Campistol JM; Miró O; Garcés N; Soy D; Grau JM
    Nephrol Dial Transplant; 1996 Sep; 11(9):1850-2. PubMed ID: 8918638
    [No Abstract]   [Full Text] [Related]  

  • 31. [Chronic human colchicine myopathy].
    Iwatsubo T; Ishige Y; Nukina N; Mannen T
    Rinsho Shinkeigaku; 1990 Sep; 30(9):1001-4. PubMed ID: 2265497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic cyclosporin-induced nephropathy.
    Takahara S; Ota K; Takahashi K; Uchida K; Morozumi K; Wang JD; Kyo M;
    Clin Nephrol; 2001 Jan; 55(1):69-72. PubMed ID: 11200870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myopathy with ragged red fibres following renal transplantation: possible role of cyclosporin-induced hypomagnesaemia.
    Larner AJ; Sturman SG; Hawkins JB; Anderson M
    Acta Neuropathol; 1994; 88(2):189-92. PubMed ID: 7985501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colchicine neuromyopathy: a report of six cases.
    Altiparmak MR; Pamuk ON; Pamuk GE; Hamuryudan V; Ataman R; Serdengecti K
    Clin Exp Rheumatol; 2002; 20(4 Suppl 26):S13-6. PubMed ID: 12371628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens.
    Dantal J; Hourmant M; Cantarovich D; Giral M; Blancho G; Dreno B; Soulillou JP
    Lancet; 1998 Feb; 351(9103):623-8. PubMed ID: 9500317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporin-induced gingival overgrowth: a clinical-epidemiological evaluation of 121 Italian renal transplant recipients.
    Vescovi P; Meleti M; Manfredi M; Merigo E; Pedrazzi G
    J Periodontol; 2005 Aug; 76(8):1259-64. PubMed ID: 16101356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of cyclosporin immunosuppression on serum magnesium and its fractional excretion in renal transplant recipients.
    Nawaz SH; Zafar MN; Naqvi SA; Rizvi SA
    J Pak Med Assoc; 2005 Mar; 55(3):98-100. PubMed ID: 15852743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
    Batista F; Auyanet I; Torregrosa JV; Oppenheimer F
    Transplant Proc; 2012 Nov; 44(9):2582-4. PubMed ID: 23146461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression.
    Heering PJ; Kurschat C; Vo DT; Klein-Vehne N; Fehsel K; Ivens K
    Clin Transplant; 2004 Apr; 18(2):186-92. PubMed ID: 15016134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colchicine-induced toxicity in a heart transplant patient with chronic renal failure.
    Eleftheriou G; Bacis G; Fiocchi R; Sebastiano R
    Clin Toxicol (Phila); 2008 Nov; 46(9):827-30. PubMed ID: 18608282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.